SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001808665-22-000066
Filing Date
2022-11-08
Accepted
2022-11-08 16:39:35
Documents
98
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q asrt-20220930.htm   iXBRL 10-Q 1509476
2 EX-31.1 exhibit311-q32022.htm EX-31.1 11143
3 EX-31.2 exhibit312-q32022.htm EX-31.2 11066
4 EX-32.1 exhibit321-q32022.htm EX-32.1 6037
5 EX-32.2 exhibit322-q32022.htm EX-32.2 6277
  Complete submission text file 0001808665-22-000066.txt   7499143

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20220930.xsd EX-101.SCH 54895
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asrt-20220930_cal.xml EX-101.CAL 71305
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asrt-20220930_def.xml EX-101.DEF 256754
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20220930_lab.xml EX-101.LAB 611951
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20220930_pre.xml EX-101.PRE 417729
92 EXTRACTED XBRL INSTANCE DOCUMENT asrt-20220930_htm.xml XML 1357072
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

IRS No.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39294 | Film No.: 221369515
SIC: 2834 Pharmaceutical Preparations